COLLEGIUM PHARMACEUTICAL, INC Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $34.8M, a 22.6% decline year-over-year.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $193M, a 65.3% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2023 was $167M, a 401% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2022 was $33.3M, a 89% increase from 2021.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2021 was $17.6M, a 68.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $167M +$134M +401% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $33.3M +$15.7M +89% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $17.6M -$38.6M -68.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $56.2M +$80M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$23.7M -$3.06M -14.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$20.7M +$54.8M +72.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$75.4M +$18.6M +19.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$94.1M -$67.2M -250% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$26.9M -$9.24M -52.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$17.7M -$1.62M -10.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$16M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.